Related Experiment Video
Updated: Jul 23, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Supporting the right ventricle in postcardiotomy renal dysfunction: A case series
Mami Sow1, Benjamin D Seadler2, Sonal R Chandratre3
1Medical College of Wisconsin Milwaukee Wisconsin USA.
Post-heart surgery right ventricular dysfunction can cause acute kidney injury (AKI). Using a percutaneous right ventricular assist device (RVAD) can improve kidney function and potentially prevent long-term dialysis.
Area of Science:
- Cardiology
- Nephrology
- Medical Devices
Background:
- Postcardiotomy right ventricular (RV) dysfunction is a known complication following cardiac surgery.
- This dysfunction can lead to elevated central venous pressure and subsequent congestive nephropathy, contributing to acute kidney injury (AKI).
Observation:
- Acute kidney injury (AKI) is frequently observed in patients with postcardiotomy RV dysfunction.
- Elevated central venous pressure due to RV dysfunction impairs renal perfusion and function.
Findings:
- Percutaneous insertion of a right ventricular assist device (RVAD) effectively augments cardiac output.
- RVAD insertion reduces central venous hypertension and alleviates congestive nephropathy.
Implications:
- Percutaneous RVADs offer a potential therapeutic strategy for managing AKI in the context of RV dysfunction.
- In select patients, RVADs may improve renal function and reduce the need for renal replacement therapy, such as dialysis.
More Related Videos
07:38Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
06:04Author Spotlight: Establishment and Confirmation of a Postnatal Right Ventricular Volume Overload Mouse Model
Published on: June 9, 2023
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VI: Adjunct Therapies